International Clinical Trial: Mechanistic Study of LMP1 in Regulating Aberrant Proliferation of NK/T-Cell Lymphoma

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132579) titled 'Mechanistic Study of LMP1 in Regulating Aberrant Proliferation of NK/T-Cell Lymphoma' on Sept. 15.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Peking University Shenzhen Hospital

Condition: NK/T cell lymphoma,NK cell leukemia

Intervention: NK/T-cell lymphoma group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: NK/T-cell lymphoma group:15;NK-cell leukemia group:15;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=325631

Published by HT Digital Content Se...